Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Endocrine System Diseases

• A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
• A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial
• A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
• Growth Hormone Deficiency in Mild Traumatic Brain Injury
• The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes Inadequately Controlled on Metformin.
• PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism
• A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
• A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
• A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
• Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT
• First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes
• Vitamin D Metabolism in Patients With Endocrine Disorders
• A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
• Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
• PK and PD Study of LUM-201 in Children With Growth Hormone Deficiency
• A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is
• Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia
• A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg
• A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency
• A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
• Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)
• Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer
• Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children
• Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
• Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease
• Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
• Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency
• Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency
• Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD
• A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day
• Treatment of GHD Associated With CHF
• Identification of Non-responders to Levothyroxine Therapy
• A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
• Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.
• Soluble Epoxide Hydrolase Inhibition and Insulin Resistance
• A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
• A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
• Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency
• A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency
• Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function.
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function
• A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency
• A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
• Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
• A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9
• Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
• Lipolytic Effects of GH in Hypopituitary Patients in Vivo
• A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
• Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
• Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
• Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
• Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
• Versartis International Trial in Adults With Long-Acting Growth Hormone
• Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
• Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)
• Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
• A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency
• A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency
• Testosterone Plus Finasteride Treatment After Spinal Cord Injury
• Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
• Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.
• Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy
• Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique
• Versartis Long-Term Safety Study of Somavaratan
• A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
• Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
• A Phase 3, Multicenter Study Designed To Evaluate The Efficacy And Safety Of A Long Acting Hgh Product (Mod-4023) In Adult Subjects With Growth Hormone Deficiency
• GH and Cardiovascular Risk Factors
• A Study of AZD4901 in Females With Polycystic Ovary Syndrome
• Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
• Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
• Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
• Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency
• An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)
• Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
• Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
• Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®
• Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
• Versartis Trial in Children to Assess Long-Acting Growth Hormone
• A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency
• Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency
• Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
• French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin
• Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
• First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects
• Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
• Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults
• VRS-317 in Adult Subjects With Growth Hormone Deficiency
• Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children
• One Week Comparison Study of PTH and PTHrP Infusions
• Diabetic Treatment Adherence
• Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device
• Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
• A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency
• Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study
• A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
• Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency
• Aldosterone and the Metabolic Syndrome
• Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)
• Observational Prospective Study on Patients Treated With Norditropin®
• Anterior Pituitary Hormone Replacement in Traumatic Brain Injury
• Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome
• Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
• Growth Hormone and Glucose Metabolism
• A Study of Zomacton in Children With Growth Hormone Deficiency
• Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
• Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).
• Adult Growth Hormone Deficiency and Cardiovascular Risk
• Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
• A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes
• Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
• Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency
• Treatment of Adults With Growth Hormone Deficiency
• Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial
• Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
• Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury
• Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis
• Growth Hormone Deficiency in Adults (GHDA)
• Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency
• Effect of Pegvisomant on GH/IGF-I Relationship in GHD
• rhGH Therapy on Hepatic Drug Metabolism
• A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency
• 7 Day Continuous Parathyroid Hormone IV Infusion
• 304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
• A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency
• A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency
• Treatment of Adults With Growth Hormone Deficiency
• Effect of Growth Hormone in Children With Growth Hormone Deficiency
• Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency
• Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency
• Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
• Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)
• Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)
• Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency
• Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
• Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
• Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
• Growth Retardation In Children With Special Pathological Conditions Or Disease
• Consequence of Lifetime Isolated Growth Hormone Deficiency
• Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
• Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
• Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency
• Diagnosis of Pheochromocytoma
• New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome